Protocol Ledger

NCT06015841 · Phase II · ACTIVE NOT RECRUITING

A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

Interventional Phase II clinical trial protocol NCT06015841 sponsored by AC Immune SA in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-07-24 Enrollment: 150 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06015841
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)150 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06015841
Protocol FieldVerified Registry Value
NCT IdentifierNCT06015841
Consolidated Lead SponsorAC Immune SA
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment150 participants (ESTIMATED)
Registered Start Date2023-07-24
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI